id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1999-D-0010-0001,FDA,FDA-1999-D-0010,Draft Guidance for Industry on in Vivo Pharmacokinetics and Bioavailability Studies and in Vitro Dissolution Testing for Levothyroxine Sodium Tablets; Availability,Notice,Notice of Data Availability,1999-06-15T00:00:00Z,1999,6,1999-06-15T00:00:00Z,1999-08-10T03:59:59Z,2025-05-28T09:01:12Z,99-14751,0,0,09000064804a59e3